CTRP3 attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway. 2017

Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.

Activation of hepatic stellate cells (HSCs) plays a pivotal role in the development of liver fibrosis. C1q/tumor necrosis factor-related protein 3 (CTRP3), a member of CTRPs, was involved in fibrosis. However, little is known about the role of CTRP3 in liver fibrosis. This study aimed to determine its role in liver fibrosis and explore the possible mechanism. Our results demonstrated that CTRP3 was lowly expressed in liver fibrosis tissues and activated HSCs. Overexpression of CTRP3 inhibited the proliferation and migration of HSCs, as well as suppressed the expression of extracellular matrix (ECM) in transforming growth factor-β1 (TGF-β1)-stimulated HSC-T6 cells. Furthermore, CTRP3 overexpression greatly inhibited the expression level of phosphorylation of Smad3 in TGF-β1-stimulated HSC-T6 cells. In conclusion, the present study demonstrated that CTRP3 inhibited the proliferation and migration of TGF-β1-induced HSC-T6 cells and attenuated liver fibrosis, at least in part, through inhibiting the Smad signaling pathway. These findings suggest that CTRP3 may be a promising therapeutic target for the treatment of liver fibrosis.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005109 Extracellular Matrix A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere. Matrix, Extracellular,Extracellular Matrices,Matrices, Extracellular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D048069 Tumor Necrosis Factors A family of proteins that were originally identified by their ability to cause NECROSIS of NEOPLASMS. Their necrotic effect on cells is mediated through TUMOR NECROSIS FACTOR RECEPTORS which induce APOPTOSIS. TNF Receptor Ligands,Tumor Necrosis Factor Superfamily Ligands,Necrosis Factors, Tumor,Receptor Ligands, TNF
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D051900 Smad3 Protein A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. Activated Smad3 can bind directly to DNA, and it regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling. Madh3 Protein

Related Publications

Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
January 2015, International journal of clinical and experimental medicine,
Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
September 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
December 2014, Chemico-biological interactions,
Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
October 2015, Chemico-biological interactions,
Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
August 2017, Oncotarget,
Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
November 2021, Free radical biology & medicine,
Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
April 2015, Molecular medicine reports,
Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
January 2018, Drug design, development and therapy,
Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
January 2019, Drug design, development and therapy,
Chuantao Cheng, and Shuo Yu, and Ran Kong, and Qinggong Yuan, and Yuefeng Ma, and Wenbin Yang, and Gang Cao, and Liyi Xie
March 2018, DNA and cell biology,
Copied contents to your clipboard!